Increase/Decrease in Cash: The total change in cash for the company over the given period.
Harvard Bioscience, Inc. (HBIO) had Increase/Decrease in Cash of $0.29M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
$21.97M |
|
$-4.80M |
|
$9.21M |
|
$12.77M |
|
$23.84M |
|
$-1.87M |
|
$-2.62M |
|
$-4.49M |
|
$-4.49M |
|
$-4.80M |
|
$-4.80M |
|
$-4.80M |
|
$-4.80M |
|
$-1.87M |
|
$0.03M |
|
43.61M |
|
43.61M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$46.79M |
|
$5.22M |
|
$84.45M |
|
$131.24M |
|
$22.75M |
|
$34.25M |
|
$43.17M |
|
$65.92M |
|
$65.32M |
|
$-4.46M |
|
$65.32M |
|
43.62M |
|
| Cash Flow Statement Financials | |
$-0.28M |
|
$-0.88M |
|
$1.23M |
|
$4.28M |
|
$4.57M |
|
|
Increase/Decrease in Cash |
$0.29M |
$3.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.06 |
|
-- |
|
-- |
|
0.34 |
|
0.58 |
|
58.10% |
|
-8.53% |
|
-8.53% |
|
-- |
|
-20.44% |
|
-21.86% |
|
$-2.63M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.35 |
|
1.71 |
|
52.56 |
|
-7.35% |
|
107.72% |
|
-3.66% |
|
-4.82% |
|
$1.50 |
|
$-0.06 |
|
$-0.01 |
|